Amikacin/rifampicinAcquired drug resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1730卷 / 1期

关键词：

D O I：

10.1007/s40278-018-54926-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：26 / 26

相关论文

共 50 条

[21] Ceftazidime/meropenemEmerging drug resistance: 2 case reports
Reactions Weekly, 2015, 1580 (1) : 94 - 94
[22] Multipe drugsAcquired drug resistance: 2 case reports
Reactions Weekly, 2020, 1817 (1) : 218 - 218
[23] AntibacterialsLack of efficacy and drug resistance: 2 case reports
Reactions Weekly, 2023, 1947 (1) : 49 - 49
[24] AntineoplasticsLack of efficacy and drug resistance: 2 case reports
Reactions Weekly, 2023, 1944 (1) : 84 - 84
[25] Glecaprevir/pibrentasvirVomiting and drug resistance: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 185 - 185
[26] Avibactam/ceftazidimeEmergence of drug resistance: 2 case reports
Reactions Weekly, 2019, 1771 (1) : 52 - 52
[27] AntibacterialsRash and development of drug resistance: 2 case reports
Reactions Weekly, 2021, 1836 (1) : 71 - 71
[28] Crizotinib/lorlatinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 202 - 202
[29] Avibactam/ceftazidimeAcquired drug resistance: 2 case reports
Reactions Weekly, 2025, 2051 (1) : 51 - 51
[30] Clarithromycin/ethambutol/rifampicinAcquired resistance to antimicrobials: case report
Reactions Weekly, 2018, 1704 (1) : 108 - 108

← 1 2 3 4 5 →